Some women report improved mood and mental clarity on GLP-1 medications, possibly related to better blood sugar control and increased confidence from weight loss
Ketotifen H1 + Mast Cell Stabilizer Ketotifen is frequently used as a foundational mast cell stabilizer in patients with multisystem symptoms
How many people are using GLP-1 medications By 2022, semaglutide become the dominant GLP-1 medication, accounting for 54% of use among adults with diabetes and 65% among adults without diabetes, the study noted
B12 deficiency reduces energy and metabolic efficiency, which is why semaglutide with B12 and tirzepatide with B12 combinations have gained popularity
It is crucial to note, however, that recent studies highlight significant systemic side effects of MCT4 inhibition due to its broad tissue expression, which may limit its clinical translational potential and necessitate the development of tissue-specific delivery strategies [138]